Combination of Expanded Allogeneic NK Cells and T Cell-Based Immunotherapy Exert Enhanced Antitumor Effects

Combination of Expanded Allogeneic NK Cells and T Cell-Based Immunotherapy Exert Enhanced Antitumor Effects

Immunotherapies based on immune checkpoint blockade, neoantigen-reactive tumor-infiltrating lymphocytes and T cell receptor-engineered T cells (TCR-T) have achieved favorable clinical outcomes in tumor treatment. However, sustained immune response and tumor regression have been observed only in a fe...

Full description

Bibliographic Details
Main Authors: Xiao Wang, Xuejiao Yang, Yueping Wang, Yunshuo Chen, Ying Yang, Siqi Shang, Wenbo Wang, Yueying Wang
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
natural killer cells
tumor-reactive T cells
T cell receptor-engineered T cells
human leukocyte antigen
combination immunotherapy
Online Access:https://www.mdpi.com/2072-6694/15/1/251

Similar Items

Similar Items